News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
PCI’s Managing Director Ben Dibling, PhD, Named a RealLIST Connector of 2025
The annual list features 20 individuals who collaborate with the tech community to foster inclusivity in Philadelphia
Penn Engineering’s Cherie Kagan Featured in Business Insider for Precision Agriculture Technology
Cherie Kagan, PhD, is the Stephen J. Angello Professor in Electrical and Systems Engineering in Penn Engineering.
Promising Inhibitor Combination for Hard-to-treat Leukemia Subtypes Discovered
M. Andrés Blanco, PhD, Assistant Professor, Biomedical Sciences, was one of the researchers on this team.
Penn Engineering’s Liang Feng Conducts Promising Research on Nonlinear Neural Networks to Train AI on Lightspeed
This breakthrough could dramatically speed up AI training.
New Tools for Treating Advanced Retinal Degenerations Developed by Penn Vet Researchers
Researchers at Penn Vet have developed four novel DNA promoters.
Moderna’s RSV Vaccine Receives Expanded FDA Approval
The FDA has expanded approval for Moderna's mRNA-based RSV vaccine based on Penn IP.
Dr. Jim Wilson’s Gene Therapy Work with Gemma Biotherapeutics Profiled by the Philadelphia Inquirer
Gemma Biotherapeutics was co-founded in 2024 by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Cerespectus and Vasowatch Join HiveBio’s Inaugural Cohort
HiveBio has selected its inaugural cohort of underrepresented biotech founders.
Cerespectus Accepted into Science Center’s Capital Readiness Program
Cerespectus was co-founded by Bryan Pukenas, MD, Associate Professor of Radiology in Penn Medicine.
MavriX Bio Announces FDA Clearance for Gene Therapy Trial
MavriX will initiate a clinical trial of a gene therapy for Angelman syndrome.